INSM 69.18 (-5.66%)
US4576693075BiotechnologyBiotechnology

Insmed (INSM) Financial Metrics

This table shows a selected set of financial data points of Insmed (INSM). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2024 0000-0.54363.71M-705.81M-780.18M-913.77M555.03M
2023 -5.340-5.814.35B-0.5305.21M-549.54M-673.93M-749.57M482.37M
2022 -3.910-5.112.46B-0.33245.36M-410.32M-477.72M-481.53M1.07B
2021 -3.880-7.033.05B-0.43188.46M-370.59M-358.8M-434.65M716.78M
2020 -3.010-11.053.25B-0.38164.41M-226.17M-252.07M-294.09M532.76M
2019 -3.010-7.942.02B-0.38136.47M-292.92M-230.78M-254.34M487.43M
2018 -4.220-3.111.01B-0.619.84M-272.79M-293.78M-324.28M495.07M
2017 -2.890-10.782.08B-0.550-162.62M-184.1M-192.65M381.17M
2016 -2.850-4.65818.83M-0.590-150.91M-170.24M-176.27M162.59M
2015 -2.020-91.06B-0.40-104.15M-115.28M-118.18M282.88M
2014 -1.840-8.42666.68M-0.390-69.77M-86.09M-79.16M159.23M
2013 -1.60-10.61594.66M-0.3411.5M-47.49M-54.2M-56.07M113.89M
2012 -1.560-4.29177.59M-0.280-31.3M-40.05M-41.37M90.78M
2011 -2.560-1.1971.21M-0.364.42M-31.18M-59.31M-59.66M14.85M
2010 -0.490-12.9783.48M-0.046.92M-7.72M-6.19M-6.43M10.74M
2009 9.300.8398M1.810.37M-11.01M120.32M118.35M12.74M
2008 -1.280-3.6657.4M-1.2911.7M-11.99M-13.37M-15.67M2.15M
2007 -1.740-4.7795.19M-0.837.53M-25.26M-19.56M-19.96M16.48M
2006 -5.890-1.4983.88M-2.19991K-47.22M-52.77M-56.14M24.11M
2005 -8.40-2.2993.58M-2.28131K-27.77M-28.03M-40.93M18.84M
2004 -6.950-3.1786.15M-1.27137K-24.9M-27.17M-27.2M9.22M
2003 -2.890-10.27105.73M-0.35150K-10.76M-10.2M-10.3M29.53M
2002 -11.010-0.414.55M-0.731.96M-24.08M-36.07M-36.42M27.34M
2001 -11.310-3.38125.57M-0.43296K-32.03M-35.63M-37.17M51.25M
2000 -43.60-0.863.54M-1.4860K-22.71M-78.87M-79.86M71.63M
1999 -86.440000663.16K-7.34M-7.71M-7.79M316.9K

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.

If you accept cookies, we use them to improve and personalize your experience. Manage Cookies